MASERU – Lesotho could soon introduce Lenacapavir (LEN), a breakthrough long-acting HIV prevention injection, in a major step toward ending new HIV infections and achieving epidemic control by 2030. The Ministry of Health has formally proposed the rollout of Lenacapavir to Cabinet, positioning the twice-yearly injectable drug as a critical addition to Lesotho’s HIV prevention strategy. If approved, the initiative would strengthen the country’s already strong HIV response and help close persistent prevention gaps. Lesotho’s HIV Success Story Faces Prevention Gap Lesotho remains…Continue reading with a subscriptionSubscribe for full access to every story.Subscribe - M85/monthAlready a subscriber? Sign in
Advertisement
...